18F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma-Reference-Cited by-同舟云学术

18F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma

Published:2014-05-08 Issue:8 Volume:41 Page:1501-1510
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Salaun Pierre-Yves,Campion Loïc,Ansquer Catherine,Frampas Eric,Mathieu Cédric,Robin Philippe,Bournaud Claire,Vuillez Jean-Philippe,Taieb David,Rousseau Caroline,Drui Delphine,Mirallié Eric,Borson-Chazot Françoise,Goldenberg David M.,Chatal Jean-François,Barbet Jacques,Kraeber-Bodéré Françoise

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-014-2772-0.pdf

Reference36 articles.

1. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer. 1998;83:2638–48.

2. Roman S, Lin R, Sosa JA. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer. 2006;107:2134–42.

3. Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Medullary thyroid carcinoma. Clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer. 2000;88:1139–48.

4. Tisell LE, Oden A, Muth A, Altiparmak G, Mõlne J, Ahlman H, et al. The Ki67 index a prognostic marker in medullary thyroid carcinoma. Br J Cancer. 2003;89:2093–7.

5. Barbet J, Campion L, Kraeber-Bodéré F, Chatal JF, GTE Study Group. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab. 2005;90:6077–84.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities;Reviews in Endocrine and Metabolic Disorders;2023-09-16

2. Nuklearmedizinische Diagnostik des medullären Schilddrüsenkarzinoms;Die Onkologie;2022-06-29

3. Radionuclide Therapy in Malignant Thyroid Diseases: Medullary Thyroid Cancer;Radionuclide Therapy;2022

4. Updated Review of Nuclear Molecular Imaging of Thyroid Cancers;Endocrine Practice;2021-05

5. PET in medullary thyroid carcinoma;Reference Module in Biomedical Sciences;2021